The IPO of Onyx Biotec Limited was fully subscribed for within hours of its Wednesday, November 13 launch. There was a high ...

Biotech and pharmaceutical companies are well known for raising capital through initial public offerings, or IPOs. Between ...

CEO Roberto Iacone admitted in an interview that the market remains tough, even for a biotech in the red-hot ADC world. But ...

With climbing biotech M&A and IPO activity following the post-pandemic slump, experts offer insights on maximizing value and ...

A biotech IPO prompted huge insider buying as well. And other return buyers, including Mexican billionaire Carlos Slim, stepped up again. Also: 2 Dividend Legends to Hold Forever. Beneficial owner ...

Maize-based speciality products maker Paramesu Biotech has filed preliminary papers with the capital markets regulator SEBI ...

Paramesu Biotech, a leading maize-based products manufacturer, files IPO papers with Sebi to raise Rs 600 crore. The IPO ...

Biotech and pharmaceutical companies are well known for raising capital through initial public offerings, or IPOs. Between 2001 and 2023, approximately 24% of IPOs were from biotech and ...

Paramesu Biotech Limited, a leading Indian manufacturer of maize-based products, has filed for a Rs 600 crore IPO. The company plans to use the funds ...

Between 2001 and 2023, approximately 24% of IPOs were from biotech and pharmaceutical companies. When looking at the period from 2019 to 2023, 35% of IPOs were from firms in these industries.